Search results for "Angiogenesis"

showing 10 items of 552 documents

Dynamic In Vivo Biocompatibility of Angiogenic Peptide Amphiphile Nanofibers

2009

Biomaterials that promote angiogenesis have great potential in regenerative medicine for rapid revascularization of damaged tissue, survival of transplanted cells, and healing of chronic wounds. Supramolecular nanofibers formed by self-assembly of a heparin-binding peptide amphiphile and heparan sulfate-like glycosaminoglycans were evaluated here using a dorsal skinfold chamber model to dynamically monitor the interaction between the nanofiber gel and the microcirculation, representing a novel application of this model. We paired this model with a conventional subcutaneous implantation model for static histological assessment of the interactions between the gel and host tissue. In the stati…

Materials scienceBiocompatibilityAngiogenesisBiophysicsConnective tissueBioengineeringBiocompatible Materials02 engineering and technology010402 general chemistry01 natural sciencesRegenerative medicineArticleMicrocirculationBiomaterialsMiceImplants ExperimentalFluorescence microscopemedicinePeptide amphiphileAnimalsAngiogenic ProteinsMicrocirculation021001 nanoscience & nanotechnology0104 chemical sciences3. Good healthmedicine.anatomical_structureMicroscopy FluorescenceMechanics of MaterialsNanofiberCeramics and CompositesFemaleHeparitin Sulfate0210 nano-technologyBiomedical engineering
researchProduct

Software-supported image quantification of angiogenesis in an in vitro culture system: application to studies of biocompatibility

2002

Healing of soft tissue trauma and bone discontinuities following implantation involves acute inflammatory reactions and the formation of blood vessels (angiogenesis). During angiogenesis new capillary vessels arise from the existing vasculature. Endothelial cells (EC) are the major cell type involved in angiogenesis. Corrosion of orthopaedic metallic implant materials (e.g. CoCr alloys) can cause locally high concentrations of heavy metal ions in the peri-implant tissues. Some divalent metal ions (Co2+, Ni2+, Zn2+) lead to the activation of EC in vitro. Upon exposure to these ions. EC release cytokines and chemokines and increase the expression of cell surface adhesion molecules, which repr…

Materials scienceBiocompatibilityEndotheliumAngiogenesisBiophysicsNeovascularization PhysiologicBiocompatible MaterialsBioengineeringInflammationBiomaterialsNeovascularizationAlloysImage Processing Computer-AssistedmedicineHumansCells CulturedCell adhesion moleculeMicrocirculationCobaltFluoresceinsIn vitromedicine.anatomical_structureMechanics of MaterialsCeramics and CompositesBiophysicsEndothelium Vascularmedicine.symptomWound healingSoftwareBiomedical engineeringBiomaterials
researchProduct

The role of angiogenesis in implant dentistry part I: Review of titanium alloys, surface characteristics and treatments

2015

Background: Angiogenesis plays an important role in osseointegration process by contributing to inflammatory and regenerative phases of surrounding alveolar bone. The present review evaluated the effect of titanium alloys and their surface characteristics including: surface topography (macro, micro, and nano), surface wettability/ energy, surface hydrophilicity or hydrophobicity, surface charge, and surface treatments of dental implants on angiogenesis events, which occur during osseointegration period. Material and Methods: An electronic search was performed in PubMed, MEDLINE, and EMBASE databases via OVID using the keywords mentioned in the PubMed and MeSH headings regarding the role of …

Materials scienceSurface PropertiesAngiogenesismedicine.medical_treatmentNeovascularization PhysiologicDentistrychemistry.chemical_elementOdontologíaReview02 engineering and technologyOsseointegrationNeovascularization03 medical and health sciences0302 clinical medicineOsseointegrationAlloysmedicineDental Prosthesis DesignHumansDental implantGeneral DentistryDental alveolusDental ImplantsTitaniumbusiness.industry030206 dentistry:CIENCIAS MÉDICAS [UNESCO]021001 nanoscience & nanotechnologyCiencias de la salud3. Good healthstomatognathic diseasesDental Prosthesis DesignOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASSurface modificationSurgeryOral Surgerymedicine.symptom0210 nano-technologybusinessTitaniumMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

2017

Joint replacement surgery is associated with significant morbidity and mortality following infection with either methicillin-resistant Staphylococcus aureus (MRSA) or Staphylococcus epidermidis. These organisms have strong biofilm-forming capability in deep wounds and on prosthetic surfaces, with 103 -104 microbes resulting in clinically significant infections. To inhibit biofilm formation, we developed 3D titanium structures using selective laser melting and then coated them with a silver nanolayer using atomic layer deposition. On bare titanium scaffolds, S. epidermidis growth was slow but on silver-coated implants there were significant further reductions in both bacterial recovery (p < …

Materials sciencebiologyAngiogenesisJoint replacementmedicine.medical_treatment0206 medical engineeringBiomedical EngineeringBiofilmPharmaceutical Sciencechemistry.chemical_element02 engineering and technology021001 nanoscience & nanotechnologybiology.organism_classificationmedicine.disease_cause020601 biomedical engineeringOsseointegrationBiomaterialschemistryStaphylococcus epidermidisIn vivoStaphylococcus aureusmedicine0210 nano-technologyBiomedical engineeringTitaniumAdvanced Healthcare Materials
researchProduct

Structural and Functional Characterization of Chronic Obstructive Lung Disease and Emphysema Using 3He- MRI: Comparison with CT and Pulmonary Functio…

2005

mor types. For these reasons, Matrigel impregnated with angiogenic hormone, basic-Fibroblast Growth Factor (bFGF), in a mouse model has been extensively used in fundamental angiogenesis research to induce endothelial cell differentiation and successfully allow the study of different phases of the angiogenesis process. The objective of this study was to evaluate the ability of functional ultrasound imaging (fUSI) to provide data allowing the quantification of the angiogenic process, using the Matrigel model.

MatrigelPathologymedicine.medical_specialtyAngiogenic ProcessAngiogenesisbusiness.industryGrowth factormedicine.medical_treatmentmedicine.diseaseEndothelial cell differentiationObstructive lung diseasePulmonary function testingUltrasound imagingmedicineRadiology Nuclear Medicine and imagingbusinessAcademic Radiology
researchProduct

Pharmacologic therapies in endometriosis: a systematic review

2012

To assess the literature on preclinical and clinical efficacy and safety data of pharmacologic groups proposed in the treatment of endometriosis, we performed a systematic review of publications from March 2002 to January 2012 via PubMed search. Additional relevant articles were identified from citations within these publications. A high number of medications were tested in preclinical models of endometriosis due to their theoretic capacity of disrupting important pathophysiologic pathways of the disease, such as inflammatory response, angiogenesis and cell survival, proliferation, migration, adhesion, and invasion. Tumor necrosis factor α-blockers, nuclear factor κB inhibitors, antiangioge…

Matrix metalloproteinase inhibitorAngiogenesisAnti-Inflammatory AgentsEndometriosisEndometriosisAngiogenesis InhibitorsPharmacologyp38 Mitogen-Activated Protein KinasesAntioxidantsEtanerceptmedicineAnimalsHumansHyaluronic AcidAdverse effectMelatoninTumor Necrosis Factor-alphabusiness.industryNF-kappa BObstetrics and Gynecologymedicine.diseaseMetforminReproductive MedicineEstrogen inhibitorFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsEndostatinbusinessmedicine.drugFertility and Sterility
researchProduct

Dynamics of CXC group chemokine platelet factor 4 (PF4) plasma levels in non-small cell lung cancer (NSCLC)

2012

CXC chemokines display pleiotropic effects participating not only in inflammation, but regulating angiogenesis and metastatic spread in cancer. Platelet factor 4 (PF4) is a 70-amino acid protein belonging to the CXC chemokine family. PF4 is also known as CXCL4. This chemokine is released from alpha-granules of activated platelets and binds with high affinity to heparin-like molecules promoting coagulation. Megakaryocytes respond to the presence of tumors by increasing their number in the bone marrow accompanied by increase in the number of platelets in circulation, causing changes in chemokine balance.

Medicine(all)ChemokinebiologyBiochemistry Genetics and Molecular Biology(all)Angiogenesisbusiness.industrylcsh:Rlcsh:MedicineCancerInflammationGeneral Medicinemedicine.diseaseGeneral Biochemistry Genetics and Molecular Biologymedicine.anatomical_structurePoster PresentationImmunologymedicinebiology.proteinPlateletPlatelet activationBone marrowmedicine.symptombusinessPlatelet factor 4Journal of Translational Medicine
researchProduct

The Expression and Prognostic Significance of VEGF and CXCR4 in Gastric Cancer: Correlation with Angiogenesis, Lymphangiogenesis and Progression

2022

The cellular response to hypoxia includes the expression of hypoxia-inducible factor-1 (HIF-1) and its target genes: vascular endothelial growth factor (VEGF) and CXC chemokine receptor 4 (CXCR4). The aim of this study was to investigate the expression and prognostic significance of VEGF and CXCR4, which are responsible for angiogenesis and progression in gastric cancer. Twenty-eight gastric cancer patients were analyzed. The mRNA expression was examined in primary tumors and corresponding normal gastric mucosa by RT-PCR. The protein level was examined by immunohistochemistry staining. The high expression of VEGF and CXCR4 was found in 71.0 and 64.0% of tumors, respectively. The mean levels…

Microbiology (medical)gastric cancer; VEGF; CXCR4; angiogenesis; lymphangiogenesis; lymph node metastasesGeneral MedicineMolecular BiologyMicrobiologyCurrent Issues in Molecular Biology
researchProduct

Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d[pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2

2015

Vascular Endothelial Growth Factor (VEGF) pathway has emerged as one of the most important positive modulators of Angiogenesis, a central process implicated in tumour growth and metastatic dissemination. This led to the design and development of anti-VEGF monoclonal antibodies and small-molecule ATP-competitive VEGFR-inhibitors. In this study, we describe the synthesis and the biological evaluation of novel 2-aryl substituted benzothiopyrano-fused pyrimidines 1a-i, 2a-i and 3a-i. The ability of the compounds to target the VEGF pathway was determined in vitro exploiting the compounds' antiproliferative efficacy against HUVEC cells. The VEGFR-2 inhibition was confirmed by enzymatic assays on …

Models MolecularAngiogenesisReceptor tyrosine kinaseCellAntineoplastic AgentsReceptor tyrosine kinaseBenzothiopyranopirimidines; Kinase inhibitors; Receptor tyrosine kinases; Tumor angiogenesis; VEGFR;Tumor angiogenesisStructure-Activity Relationshipchemistry.chemical_compoundVEGFRBenzothiopyranopirimidineCell Line TumorReceptor tyrosine kinasesDrug DiscoveryHuman Umbilical Vein Endothelial CellsmedicineHumansProtein Kinase InhibitorsCell ProliferationPyransTumor angiogenesiPharmacologyKinase inhibitorDose-Response Relationship DrugMolecular StructurebiologyKinaseCell growthOrganic ChemistryKinase insert domain receptorGeneral MedicineVascular Endothelial Growth Factor Receptor-2Molecular biologyVascular endothelial growth factorPyrimidinesmedicine.anatomical_structureBenzothiopyranopirimidineschemistryBenzothiopyranopirimidines; Kinase inhibitors; Receptor tyrosine kinases; Tumor angiogenesis; VEGFRKinase inhibitorsCancer researchbiology.proteinDrug Screening Assays AntitumorEx vivo
researchProduct

Design, Synthesis, and Biological Evaluation of 3,4-Diarylmaleimides as Angiogenesis Inhibitors

2006

The new analogue 2 of combretastatin A-4 was discovered to be an inhibitor of tubulin polymerization with an IC50 of 7.6 microM and reduced angiogenesis in the in vivo chick embryo model. Interestingly, in a series of 2,3-diarylmaleimides closely related to this lead, no other compound was found to be active in the tubulin polymerization assay. However, by screening in the in vivo chick embryo assay 10 was identified as a potent angiogenesis inhibitor indicating an alternative target. Indeed, molecular modeling studies suggest a reasonable binding mode of 10 at the ATP-binding site of the model kinase CDK2. Motivated by these results, analogues of 10 were screened for inhibitory activity in…

Models MolecularIndolesanimal structuresAngiogenesisAngiogenesis InhibitorsChick EmbryoIn Vitro TechniquesMaleimidesStructure-Activity Relationshipchemistry.chemical_compoundAdenosine TriphosphateIn vivoDrug DiscoveryAnimalsStructure–activity relationshipPyrrolesBinding siteCombretastatinBinding SitesbiologyChemistryKinaseCyclin-dependent kinase 2Vascular Endothelial Growth Factor Receptor-2Angiogenesis inhibitorBiochemistryDrug Designbiology.proteinMolecular MedicineJournal of Medicinal Chemistry
researchProduct